Confirm Your Residency
This Website Contains Information on Equus SICAV - Ascender Asia Value Fund
The fund discussed on this web site is not offered outside its intended countries and transactions will only be accepted from qualified investors. This information is intended to supplement information contained in the fund prospectus and must be read in conjunction therewith. No information in this section constitutes an offer of fund shares or of any securities mentioned. Please read the prospectus and key investor information document carefully.
This product section contains information covering an investment fund registered in different locations around the world. As such, access to the information contained herein may be restricted by laws and regulations applicable to the user. This information is not intended to be published or made available to any person in any jurisdiction where doing so would result in contravention of any applicable laws or regulations. The user should ensure that the use of this information and the making of any investment as a result does not contravene any such restrictions. It is the user's responsibility to be informed and to observe, all applicable laws and regulations of any relevant jurisdiction.
Neither Ascender Capital Limited nor anyone else involved in creating, producing or delivering the website shall be liable for any damage arising out of use of the website.
You should be aware of the risks associated with equity investment. Past performance is not indicative of future performance. Returns will fluctuate with changing market conditions, taxes, exchange rates and sales charges. Due to the increasing rate of changes in regulations and the unpredictability in how tax authorities divergently interpret existing laws, these companies cannot assume any liability for the effects of any particular tax issues. Independent financial advice should be taken before entering into any financial transaction.
The Equus SICAV – Ascender Asia Value Fund is authorized and available in Luxembourg and Switzerland.